Zhejiang Orient Gene Biotech has been targeted on defending innovations in United States(US) with 16 publications in Q3 2023
The USA(US) Patent Workplace dominates the patent filings and grants with practically 17% filings and 68% grants. The China(CN), United States(US), Canada(CA), and European Patent Workplace (EP) patent Workplace are among the many prime ten patent places of work the place Zhejiang Orient Gene Biotech is filings its patents. Among the many prime granted patent authorities, Zhejiang Orient Gene Biotech has 68% of its grants in United States(US), 26% in China(CN), and 5% in Canada(CA).
Fujifilm might be the strongest competitor for Zhejiang Orient Gene Biotech
Fujifilm and Sekisui Chemical secured the highest positions in keeping with latest patent publication knowledge.
Entry probably the most complete Firm Profiles
available on the market, powered by GlobalData. Save hours of analysis. Acquire aggressive edge.
Firm Profile – free
pattern
Your obtain e-mail will arrive shortly
We’re assured concerning the
distinctive
high quality of our Firm Profiles. Nonetheless, we would like you to take advantage of
useful
resolution for your small business, so we provide a free pattern that you may obtain by
submitting the beneath type
By GlobalData
Patents associated to industrial automation and healthtech lead Zhejiang Orient Gene Biotech’s portfolio
Zhejiang Orient Gene Biotech has the best variety of patents in industrial automation adopted by, healthtech and local weather change. For industrial automation, practically 50% of patents had been filed and 0% of patents had been granted in Q3 2023.
First assist and wound care associated patents lead Zhejiang Orient Gene Biotech portfolio adopted by normal surgical procedure units, and hospital provides
Zhejiang Orient Gene Biotech has highest variety of patents in first assist and wound care adopted by normal surgical procedure units, hospital provides, and . For first assist and wound care, practically 33% of patents had been filed and 0% of patents had been granted in Q3 2023.
For complete evaluation of Zhejiang Orient Gene Biotech’s filings and grants, buy the databook here.
Trending Merchandise
